Northeast Pharmaceutical Group Co., Ltd ( NEPG )
Our NEPG welcome your feedback, questions, comments and/or requests.
Please contact persons in the list below to get a response.
ADDRESS: 19th floor, Block B, Chamber of Commerce Headquarter Mansion. No.51, The Youth Street, Shenhe District, Shenyang China.
Fax:0086 24 22724536
Hexadeca-μ-hydroxytetracosahydroxy[μ8-[1,3,4,6-tetra-O-sulfo-β-Dfructofuranosyl-α-D-glucopyranoside tetrakis(hydrogen sulfato)8-)]]hexadecaaluminu
Sucralfate is a cytoprotective agent, an oral gastrointestinal medicationprimarily indicated for the treatment of active duodenal ulcers.Sucralfate is also used for the treatment of gastroesophageal reflux disease and stressulcers. Unlike the other classes of medications used for treatment of peptic ulcers, sucralfate is a sucrose sulfate-aluminium complex that binds to the mucosa, thus creating a physical barrier that impairs diffusion of hydrochloric acid in the gastrointestinal tract and prevents degradation of mucus by acid. It also stimulates bicarbonate output and acts like an acid buffer with cytoprotective properties. Sucralfate was approved by the U.S. Food and Drug Administration (FDA) in 1981.
* FDA approved
* Micronized powder(50mm) could be supplied